Anesthesia Pharmacology Chapter 
6:  Autonomic (ANS) Pharmacology 
Practice Questions
	Click on the correct answer.
 
 
 
- Drugs activating this receptor are used in treating asthma: -   beta1 adrenergic
-   muscarinic cholinergic
-   beta2 adrenergic
-   nicotinic cholinergic
 
- Epinephrine effects on the heart -   increased rate
-   decreased contractility
-   coronary vasodilation
-   A & C
 
- Receptor activation mainly responsible for positive inotropism: -   alpha1
-   beta1
-   dopamine D1
-   muscarinic cholinergic
 
- Epinephrine effects on respiration: -   stimulation
-   inhibition
 
- Activates alpha receptors -   isoproterenol (Isuprel)
-   propranolol (Inderal)
-   phenylephrine (Neo-Synephrine)
-   terbutaline (Brethine)
 
- Blocks cardiac isoproterenol effects -   terbutaline (Brethine)
-   esmolol (Brevibloc)
-   atropine
-   mecamylamine (Inversine)
 
- Alpha agonist: vasoconstriction and elevates blood pressure: -   metoprolol (Lopressor)
-   methoxamine (Vasoxyl)
-   terbutaline (Brethine)
-   ipratropium (Atrovent)
 
- Nerve terminal reuptake inhibitor -   methoxamine (Vasoxyl)
-   cocaine
-   reserpine
-   timolol (Blocadren)
 
- Alpha adrenoceptor COVALENT blocker: -   propranolol (Inderal)
-   phenoxybenzamine (Dibenzyline)
-   phentolamine (Regitine)
-   pilocarpine (Pilocar)
 
- Orthostatic (postural) hypotension -   beta receptor activation
-   alpha receptor activation
-   alpha receptor blocker
-   dopamine receptor blockade
 
- Norepinephrine pressor response blocked by: -   mecamylamine (Inversine)
-   prazosin (Minipress)
-   atropine
-   propranolol (Inderal)
 
- Bronchodilation -   ipratropium (Atrovent)
-   timolol (Blocadren)
-   albuterol (Ventolin,Proventil)
-   A & C
 
- Positive chronotropic effects of epinephrine: -   increased SA nodal potassium current
-   beta1 receptor activation
-   mediated by G protein
-   B & C
 
- Maximal ß-adrenergic receptor desensitization depends on: -   receptor occupancy by agonists
-   an arrestin protein
-   receptor phosphorylation
-   A, B & C
 
- Phase of the cardiac action potential that principally determine heart rate -   phase 0
-   phase 4
-   phase 2
-   phase 3
 
- Most likely to increase myocardial afterload -   angiotensin converting enzyme inhibitor (decreases angiotensin II concentration)
-   propranolol (Inderal)
-   phenylephrine (Neo-Synephrine)
-   low-dose epinephrine
 
- Pressor effects of epinephrine are blocked by this drug ("epinephrine reversal") -   propranolol (Inderal)
-   phentolamine (Regitine)
-   phenylephrine (Neo-Synephrine)
-   metoprolol (Lopressor)
 
- Decreases blood pressure -   propranolol (Inderal)
-   mecamylamine (Inversine)
-   phentolamine (Regitine)
-   all of the above
 
- Specific alpha2 receptor agonist -   phenoxybenzamine (Dibenzyline)
-   propranolol (Inderal)
-   guanfacine (Tenex)
-   methoxamine (Vasoxyl)
 
- Centrally-acting antihypertensive drug -   nitroprusside sodium (Nipride)
-   clonidine (Catapres)
-   methoxamine (Vasoxyl)
-   captopril (Capoten)